Bristol-Myers Squibb Company (BMY) · page 153 of 197
The slide uses a precedent (Amgen) to argue for a specific operational strategy at the target company (Bristol-Myers).
Activist deck · peer_benchmark · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 6/8
callout 0/1 chart 2/2 metric 0/1 paragraph 1/1 source-note 1/1 title 2/2
2 without position callout 1 · metric 1
calloutmetric · primary
Components 8
callout bar-vertical bar-vertical primary paragraph source-note action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1